Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs TRYM Health

By GLP-1 ScorecardUpdated

PlexusDxFactor scores not reassessed.
Site position #112

Lower score

TRYM HealthFactor scores not reassessed.
Site position #114

Higher score

Score comparison

TRYM Health has the higher recorded score — 70.6/100 to 67.7/100.

TRYM Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose vials covering all doses, with a starter kit, temperature-controlled shipping, FSA/HSA eligibility, and flexible cancellation.

Before you choose

Before comparing the headline prices, the PlexusDx review and the TRYM Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Auren Rx vs PlexusDx and Queen RX vs TRYM Health compare each of them with another graded program, and the list of alternatives to PlexusDx ranks the programs closest to PlexusDx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTRYM Health +22
74
96
Dose & formulationTRYM Health +8
64
72
Clinical oversightPlexusDx +19
74
55
Labs & monitoringTRYM Health +1
52
53
FulfillmentPlexusDx +4
78
74
Contract termsEven
55
55
PlexusDx · top barTRYM Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPlexusDxTRYM Health
WeighScore67.7/10070.6/100
GradeCC
Site position#112#114
Semaglutide$99/mo (12-month plan; compounded)$96/mo (all doses, compounded)
Tirzepatide$129/mo (12-month plan; compounded)$126/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
PlexusDx

Site position #112 · C

Factor scores not reassessed.

Strengths

  • Licensed providers available in all 50 states
  • Range of options including microdose GLP-1 from $69/mo on a 12-month plan
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

What to consider

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • The advertised $99 semaglutide and $129 tirzepatide rates require a 12-month plan; shorter-term prices were not visible
  • No insurance accepted
TRYM Health

Site position #114 · C

Factor scores not reassessed.

FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

What to consider

  • Compounding pharmacy partner not named
  • LegitScript certification was not documented on the public pages reviewed
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
  • FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

PlexusDx

Factor scores not reassessed.

PlexusDx scores 67.7/100 (C). PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard